Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Blockade of VEGF alone is sufficient to prevent blinding illness

Feb. 21, 2000

No Comments

Novel Merck compounds inhibit KDR kinase and VEGF activity

Feb. 15, 2000

No Comments

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

No Comments

FDA issues approvable letter for Visudyne

Feb. 14, 2000

No Comments

New ophthalmic gene licensed by InSite

Feb. 10, 2000

No Comments

Oculex updates intraocular drug delivery pipeline

Feb. 4, 2000

No Comments

Visudyne market introduction announced

Feb. 2, 2000

No Comments

Are cannabinoid receptors involved in the IOP-lowering effects of cannabinoids?

Feb. 2, 2000

No Comments

InSite Vision licenses novel TIGR modifier gene

Feb. 2, 2000

No Comments

Alcon makes milestone payment to Pharmacyclics for Optrin

Feb. 1, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Blockade of VEGF alone is sufficient to prevent blinding illness

Novel Merck compounds inhibit KDR kinase and VEGF activity

Ophthalmic antibacterial on the way to market in Japan

FDA issues approvable letter for Visudyne

New ophthalmic gene licensed by InSite

Oculex updates intraocular drug delivery pipeline

Visudyne market introduction announced

Are cannabinoid receptors involved in the IOP-lowering effects of cannabinoids?

InSite Vision licenses novel TIGR modifier gene

Alcon makes milestone payment to Pharmacyclics for Optrin

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Radiopharma Telix acquires FAP-targeting agents for bladder cancer

Ocular RSS

Ocular
RSS